Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis
about
Pharmacotherapy for uveitis: current management and emerging therapy.AAV2-mediated combined subretinal delivery of IFN-α and IL-4 reduces the severity of experimental autoimmune uveoretinitisMinicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type IThe effect of toll-like receptor 4 in the aqueous humor of endotoxin-induced uveitis.Impact of IL-1 signalling on experimental uveitis and arthritis.Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells.Multimodal analysis of ocular inflammation using the endotoxin-induced uveitis mouse model.New options for uveitis treatment.Flow cytometric analysis of inflammatory and resident myeloid populations in mouse ocular inflammatory modelsPrimate neural retina upregulates IL-6 and IL-10 in response to a herpes simplex vector suggesting the presence of a pro-/anti-inflammatory axis.Ocular gene delivery using lentiviral vectors.New biologic-response modifiers in ocular inflammatory disease: beyond anti-TNF treatment.Gene therapy for noninfectious uveitis.A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II.Unmet Needs and Future Directions in Inflammatory Eye Disease.Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis.Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.The diagnosis and treatment of primary vitreoretinal lymphoma: a review.Bevacizumab Diminishes Inflammation in an Acute Endotoxin-Induced Uveitis Model.
P2860
Q34274075-9EEAC7E0-17D7-4778-8476-A32EBA88F9A9Q34299556-AFC3713A-BAA7-4BC1-A476-98334564C541Q34621690-EDABC7F1-6F84-4A0D-AA49-51AA05BCF0C5Q35795864-EBB5B44A-DD65-4693-881E-6F1599EC2370Q35909794-718584CC-4184-49FC-A1E1-69082E98797CQ36220670-CB437791-7C29-43C3-92AF-AACF444A10C0Q36856021-FD18BF84-8148-46C4-8ECA-73A369C6371DQ37256887-C7898088-97FD-4BF3-8E80-0E381CD0039EQ37316781-88F4A261-D42C-43D0-81D8-F272C4BA9D43Q37331180-BDB1D345-7D5B-47C9-8B80-0D1BBB8D8D2DQ37952564-A0147363-4537-48F8-B632-CB88B379AFDEQ38057370-4B725589-3BEC-469F-8FF2-1C6E88DCB021Q38060848-E0411F77-8FA9-4619-AE1B-051A21E3191FQ38250103-DEA5B696-CF04-4D2D-A980-584A118F8FF4Q38806044-65BD5781-FC4F-440A-857A-B42C9B061BA8Q41146908-FDB6BBCA-A086-4139-96C9-7BCCD6FB8F52Q45857204-7BDDDCAA-0682-446C-80DA-682D65C34F9BQ47442388-DF005992-C460-406F-866E-FEDB9BCD9830Q52768652-06348B91-1342-41B1-960C-FDFB37CE5585Q55005388-30EB89D4-508B-45FC-9F47-EBB7865FB736Q55412994-D24F945B-B174-4314-9F34-569805B715B1
P2860
Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Lentiviral-vector-mediated exp ...... y of endotoxin-induced uveitis
@ast
Lentiviral-vector-mediated exp ...... y of endotoxin-induced uveitis
@en
type
label
Lentiviral-vector-mediated exp ...... y of endotoxin-induced uveitis
@ast
Lentiviral-vector-mediated exp ...... y of endotoxin-induced uveitis
@en
prefLabel
Lentiviral-vector-mediated exp ...... y of endotoxin-induced uveitis
@ast
Lentiviral-vector-mediated exp ...... y of endotoxin-induced uveitis
@en
P2093
P2860
P356
P1433
P1476
Lentiviral-vector-mediated exp ...... y of endotoxin-induced uveitis
@en
P2093
C A Broderick
M Natkunarajah
P Trittibach
S E Barker
S J Robbie
P2860
P2888
P304
P356
10.1038/GT.2008.109
P577
2008-06-26T00:00:00Z